Literature DB >> 21900332

Transradial access for renal artery intervention is feasible and safe.

Oluseun Alli1, Verghese Mathew, Aaron M From, Gregory Barsness, Sanjay Misra, Rajiv Gulati.   

Abstract

BACKGROUND: Transradial access for coronary intervention is associated with reduced access complications compared with transfemoral. Transradial access for renal artery intervention has been less well studied. Safety compared with transfemoral access is undetermined. METHODS AND
RESULTS: We evaluated the feasibility of transradial renal intervention (n = 11 patients) and compared safety parameters with a matched group of transfemoral controls (n = 44). All transradial interventions were successful with no complications. Femoral crossover was required in one due to insufficient guide length. Compared with transfemoral, there were fewer access complications in the transradial group (0 of 11 vs 3 of 44, P = .06) but no differences in fluoroscopy time or contrast volumes (25.3 ± 14.4 vs 29.0 ± 25.1 minutes, P = .47; 83.0 ± 43.7 vs 82.6 ± 35.2 cc, P = .97). At follow-up (median 6 months), radial patency was 100%. Creatinine and systolic blood pressure had decreased (mean 1.4 ± 0.5 to 1.2 ± 0.5, P = .06; 160 ± 25 to 135 ± 17, P = .009).
CONCLUSIONS: Elective transradial renal intervention is feasible and safe. Radial-renal distance is a limitation with available guides.

Entities:  

Mesh:

Year:  2011        PMID: 21900332     DOI: 10.1177/1538574411418845

Source DB:  PubMed          Journal:  Vasc Endovascular Surg        ISSN: 1538-5744            Impact factor:   1.089


  2 in total

1.  Comparison of transradial and transfemoral access for transcatheter arterial embolization of iatrogenic renal hemorrhage.

Authors:  Chuanwu Cao; So-Yeon Kim; Gun Ha Kim; Ji Hoon Shin; In Chul Nam; Meshari Alali; Hee Ho Chu; Heung-Kyu Ko
Journal:  PLoS One       Date:  2021-08-20       Impact factor: 3.240

2.  Renal Arteriography via Radial Artery Access with a 125 cm Long Angiographic Catheter.

Authors:  Ji-Xuan Liu; Zhi-Jun Sun; Jin-Da Wang
Journal:  Biomed Res Int       Date:  2021-04-23       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.